← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2020Last known activity
Oct 15, 2025
Timeline
2000s
- Jun 1, 2006
EyeGene Inc.— Founded
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT07204457Lead sponsorPhase 2/Phase 3Oct 15, 2025
- NCT06099613Lead sponsorPhase 1/Phase 2Oct 23, 2023
- NCT05188469Lead sponsorPhase 1/Phase 2Mar 22, 2022
- NCT04210752Lead sponsorPhase 1Feb 1, 2020
Details
- Founded
- Seoul, KR Jun 1, 2006
- Last known activity
- Oct 15, 2025